Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99.6M
-
Number of holders
-
353
-
Total 13F shares, excl. options
-
90.4M
-
Shares change
-
+1.81M
-
Total reported value, excl. options
-
$7.83B
-
Value change
-
+$142M
-
Put/Call ratio
-
0.82
-
Number of buys
-
174
-
Number of sells
-
-196
-
Price
-
$86.55
Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q1 2020
452 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q1 2020.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 353 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.4M shares
of 99.6M outstanding shares and own 90.79% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.5M shares), JANUS HENDERSON GROUP PLC (7.63M shares), FMR LLC (7.28M shares), BlackRock Inc. (6.96M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.57M shares), Capital International Investors (6.02M shares), Bellevue Group AG (3.26M shares), PERCEPTIVE ADVISORS LLC (3.06M shares), STATE STREET CORP (2.51M shares), and FRANKLIN RESOURCES INC (1.68M shares).
This table shows the top 353 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.